Veraxa Biotech AG - Post de-SPAC (VRXA) Insider Trading -- Recent Executive & Director Transactions
5 insiders reported 6 Form 4 transactions for Veraxa Biotech AG - Post de-SPAC (VRXA) over the past 18 months (most recent 2026-10-29). Recent activity: Gruninger Marc (Director) Buy 867 shares, Gruninger Marc (Director) Buy 9,133 shares, Ziegler Christoph Samuel (Director) Buy 30,000 shares, Hosseinion Warren (Director) Buy 6,024 shares, Antz Christoph Rudiger (Chief Executive Officer) Buy 5,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-29 | Gruninger Marc | Director | Buy | 867 | $850 |
| 2026-10-29 | Gruninger Marc | Director | Buy | 9,133 | $9,133 |
| 2026-10-21 | Ziegler Christoph Samuel | Director | Buy | 30,000 | $32,700 |
| 2026-09-29 | Hosseinion Warren | Director | Buy | 6,024 | $10,060 |
| 2026-08-31 | Antz Christoph Rudiger | Chief Executive Officer | Buy | 5,000 | $7,650 |
| 2026-08-31 | Baumann Oliver Rolf | Director | Buy | 50,000 | $75,000 |
Source: SEC Form 4 filings · as of 2026-10-29